Skip to content
  • English
  • Français
  • Projects and financing

    Funding opportunities

    Funded projects

  • News

    News

    Events

  • About us

    Mission

    Strategic plan

    Team

    Patients

    Partners

  • Blog
  • Contact us
  • English
  • Français

Virtual midlife follow-up by teleconsultation for cancer patients receiving cancer treatment in a tablet: an evaluability study essential for optimizing access to care

Virtual midlife follow-up by teleconsultation for cancer patients receiving cancer treatment in a tablet: an evaluability study essential for optimizing access to care

Home » Funded projects » Virtual midlife follow-up by teleconsultation for cancer patients receiving cancer treatment in a tablet: an evaluability study essential for optimizing access to care

Changes during the pandemic have meant that people affected by cancer are relying more and more on teleconsultation, also known as virtual midlife follow-up via the Internet, using a computer or tablet.

Research shows that teleconsultation brings benefits in terms of access to care, the relationship between professionals and patients and their loved ones, the ability to take care of oneself, and reduced transport and parking costs. These benefits depend on the characteristics of the people providing and receiving care. Some people prefer face-to-face consultations and do not wish to continue teleconsulting after the pandemic. For others, a virtual follow-up could be envisaged, provided that individual needs and preferences are taken into account. We want virtual follow-up to be a choice, not an obligation. We also know that benefits vary according to environment or geographic location. In Quebec, there is little research to help us better understand how this virtual follow-up is set up, for which people, with which member of the oncology team and under what conditions.

The proposed research focuses on the importance of properly organizing the growing use of virtual monitoring in the living environment. We’ll be looking at how virtual follow-up in the midlife setting is being implemented for sufferers receiving oral anticancer drugs, and which ways of doing things hold the most promise for continuing to deliver safe, quality care by the right person, at the right time, in the right place. Our study will determine the acceptability and feasibility of virtual follow-up in the living environment, from the perspective of the people involved in this new model of care, with a view to determining what works well and what needs to be improved to continue towards this approach to care.

Our research will provide new insights into the deployment of virtual follow-up in the living environment, taking into account Quebec’s priorities for modernizing care and services for people affected by cancer. The results will help inform decisions by integrating aspects of care and how to organize it effectively to offer choices that give the best possible chance of coping with cancer and contribute to the best possible quality of life.

Principal Investigator

Dominique Tremblay
Sherbrooke University

Co-researchers

Marie-Claude Battista
Sherbrooke University
Djamal Berbiche
Sherbrooke University
José Côté
University of Montreal
Brigitte Guérin
Sherbrooke University
Thomas Joly-Mischlich
CIUSSS de l'Estrie - CHUS
Frédéric Lemay
CIUSSS de l'Estrie - CHUS
Éric Maillet
Sherbrooke University
Michel Pavic
CIUSSS de l'Estrie - CHUS
Sara Soldera
CISSS de la Montérégie-Centre
Catherine Wilhelmy
Sherbrooke University

In a nutshell

Principal Investigator

Dominique Tremblay

Competitions

ACCES-Onco

Status

In progress

Start

07 2023

Scheduled finish

07 2025

Budget

200 000 $
Newsletter
Social networking
Linkedin-in

Projets et financement

Opportunités de financement

Projets financés

Actualités

Nouvelles

Événements

À propos

Mission

Plan stratégique

Équipe

Patients

Partenaires

Blogue

Contact

  • English
  • Français

Projects and financing

Funding opportunities

Funded projects

News

News

Events

About us

Mission

Strategic plan

Team

Patients

Partners

Blog

Contact us

  • English
  • Français